Literature DB >> 19680247

Waves of resistance: Staphylococcus aureus in the antibiotic era.

Henry F Chambers1, Frank R Deleo.   

Abstract

Staphylococcus aureus is notorious for its ability to become resistant to antibiotics. Infections that are caused by antibiotic-resistant strains often occur in epidemic waves that are initiated by one or a few successful clones. Methicillin-resistant S. aureus (MRSA) features prominently in these epidemics. Historically associated with hospitals and other health care settings, MRSA has now emerged as a widespread cause of community infections. Community or community-associated MRSA (CA-MRSA) can spread rapidly among healthy individuals. Outbreaks of CA-MRSA infections have been reported worldwide, and CA-MRSA strains are now epidemic in the United States. Here, we review the molecular epidemiology of the epidemic waves of penicillin- and methicillin-resistant strains of S. aureus that have occurred since 1940, with a focus on the clinical and molecular epidemiology of CA-MRSA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680247      PMCID: PMC2871281          DOI: 10.1038/nrmicro2200

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  181 in total

1.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

2.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

3.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

4.  The participation of calcium, adenosine triphosphate and adenosine triphosphatase in the extrusion of the granule proteins from the polymorphonuclear leucocyte.

Authors:  A M Woodin; A A Wieneke
Journal:  Biochem J       Date:  1964-03       Impact factor: 3.857

5.  Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.

Authors:  Anne-Laure Genestier; Marie-Cécile Michallet; Gilles Prévost; Gregory Bellot; Lara Chalabreysse; Simone Peyrol; Françoise Thivolet; Jerome Etienne; Gérard Lina; François M Vallette; François Vandenesch; Laurent Genestier
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

6.  Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Authors:  John Weigelt; Kamal Itani; Dennis Stevens; William Lau; Matthew Dryden; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Cavernous sinus thrombosis and meningitis from community-acquired methicillin-resistant Staphylococcus aureus infection.

Authors:  W J Munckhof; A Krishnan; P Kruger; D Looke
Journal:  Intern Med J       Date:  2008-04       Impact factor: 2.048

8.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

9.  Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.

Authors:  Binh An Diep; George F Sensabaugh; Naraporn Somboonna; Naraporn S Somboona; Heather A Carleton; Françoise Perdreau-Remington
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

10.  Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.

Authors:  Anne Tristan; Michele Bes; Helene Meugnier; Gerard Lina; Bülent Bozdogan; Patrice Courvalin; Marie-Elisabeth Reverdy; Mark C Enright; François Vandenesch; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

View more
  787 in total

1.  ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus.

Authors:  Matthew B Frankel; Brandon M Wojcik; Andrea C DeDent; Dominique M Missiakas; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

Review 2.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

3.  Antibiotic That Inhibits the ATPase Activity of an ATP-Binding Cassette Transporter by Binding to a Remote Extracellular Site.

Authors:  Leigh M Matano; Heidi G Morris; Anthony R Hesser; Sara E S Martin; Wonsik Lee; Tristan W Owens; Emaline Laney; Hidemasa Nakaminami; David Hooper; Timothy C Meredith; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2017-07-28       Impact factor: 15.419

4.  α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis.

Authors:  Bas G J Surewaard; Ajitha Thanabalasuriar; Zhutian Zeng; Christine Tkaczyk; Taylor S Cohen; Bart W Bardoel; Selina K Jorch; Carsten Deppermann; Juliane Bubeck Wardenburg; Rachelle P Davis; Craig N Jenne; Kendall C Stover; Bret R Sellman; Paul Kubes
Journal:  Cell Host Microbe       Date:  2018-07-19       Impact factor: 21.023

5.  Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model.

Authors:  Assaf Raz; Anna Serrano; Maneesha Thaker; Tricia Alston; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.

Authors:  Hai-Rong Lu; Mei-Gang Gu; Qiang Huang; Jin-jiang Huang; Wan-Ying Lu; Hong Lu; Qing-Shan Huang
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

7.  Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor.

Authors:  Michael E Olson; Tyler K Nygaard; Laynez Ackermann; Robert L Watkins; Oliwia W Zurek; Kyler B Pallister; Shannon Griffith; Megan R Kiedrowski; Caralyn E Flack; Jeffrey S Kavanaugh; Barry N Kreiswirth; Alexander R Horswill; Jovanka M Voyich
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

8.  NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

Authors:  Clint S Schmidt; C Jo White; Ashraf S Ibrahim; Scott G Filler; Yue Fu; Michael R Yeaman; John E Edwards; John P Hennessey
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

9.  Structural characterization of native autoinducing peptides and abiotic analogues reveals key features essential for activation and inhibition of an AgrC quorum sensing receptor in Staphylococcus aureus.

Authors:  Yftah Tal-Gan; Monika Ivancic; Gabriel Cornilescu; Claudia C Cornilescu; Helen E Blackwell
Journal:  J Am Chem Soc       Date:  2013-11-25       Impact factor: 15.419

10.  Exploring extra-cellular proteins in methicillin susceptible and methicillin resistant Staphylococcus aureus by liquid chromatography-tandem mass spectrometry.

Authors:  Shymaa Enany; Yutaka Yoshida; Tadashi Yamamoto
Journal:  World J Microbiol Biotechnol       Date:  2013-11-09       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.